GSK plc Statistics
Total Valuation
GSK plc has a market cap or net worth of 77.94 billion. The enterprise value is 95.99 billion.
| Market Cap | 77.94B |
| Enterprise Value | 95.99B |
Important Dates
The last earnings date was Monday, July 28, 2025.
| Earnings Date | Jul 28, 2025 |
| Ex-Dividend Date | Aug 14, 2025 |
Share Statistics
| Current Share Class | 4.01B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.49% |
| Shares Change (QoQ) | -0.65% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 3.90B |
Valuation Ratios
The trailing PE ratio is 16.62 and the forward PE ratio is 8.19.
| PE Ratio | 16.62 |
| Forward PE | 8.19 |
| PS Ratio | 1.80 |
| PB Ratio | 3.96 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 8.87 |
| P/OCF Ratio | 7.37 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.45, with an EV/FCF ratio of 10.93.
| EV / Earnings | 20.47 |
| EV / Sales | 2.24 |
| EV / EBITDA | 7.45 |
| EV / EBIT | 11.11 |
| EV / FCF | 10.93 |
Financial Position
The company has a current ratio of 0.87, with a Debt / Equity ratio of 1.21.
| Current Ratio | 0.87 |
| Quick Ratio | 0.56 |
| Debt / Equity | 1.21 |
| Debt / EBITDA | 1.83 |
| Debt / FCF | 2.71 |
| Interest Coverage | 10.25 |
Financial Efficiency
Return on equity (ROE) is 28.33% and return on invested capital (ROIC) is 12.75%.
| Return on Equity (ROE) | 28.33% |
| Return on Assets (ROA) | 6.78% |
| Return on Invested Capital (ROIC) | 12.75% |
| Return on Capital Employed (ROCE) | 16.38% |
| Revenue Per Employee | 631,454 |
| Profits Per Employee | 68,334 |
| Employee Count | 68,629 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 1.50 |
Taxes
In the past 12 months, GSK plc has paid 874.09 million in taxes.
| Income Tax | 874.09M |
| Effective Tax Rate | 13.80% |
Stock Price Statistics
The stock price has decreased by -4.30% in the last 52 weeks. The beta is 0.27, so GSK plc's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | -4.30% |
| 50-Day Moving Average | 19.19 |
| 200-Day Moving Average | 18.30 |
| Relative Strength Index (RSI) | 55.08 |
| Average Volume (20 Days) | 757 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GSK plc had revenue of 43.34 billion and earned 4.69 billion in profits. Earnings per share was 1.13.
| Revenue | 43.34B |
| Gross Profit | 31.07B |
| Operating Income | 8.72B |
| Pretax Income | 6.33B |
| Net Income | 4.69B |
| EBITDA | 12.73B |
| EBIT | 8.72B |
| Earnings Per Share (EPS) | 1.13 |
Balance Sheet
The company has 4.96 billion in cash and 23.78 billion in debt, giving a net cash position of -18.82 billion.
| Cash & Cash Equivalents | 4.96B |
| Total Debt | 23.78B |
| Net Cash | -18.82B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 19.67B |
| Book Value Per Share | 5.01 |
| Working Capital | -3.71B |
Cash Flow
In the last 12 months, operating cash flow was 10.58 billion and capital expenditures -1.80 billion, giving a free cash flow of 8.78 billion.
| Operating Cash Flow | 10.58B |
| Capital Expenditures | -1.80B |
| Free Cash Flow | 8.78B |
| FCF Per Share | n/a |
Margins
Gross margin is 71.69%, with operating and profit margins of 20.13% and 10.82%.
| Gross Margin | 71.69% |
| Operating Margin | 20.13% |
| Pretax Margin | 14.61% |
| Profit Margin | 10.82% |
| EBITDA Margin | 29.37% |
| EBIT Margin | 20.13% |
| FCF Margin | 20.27% |
Dividends & Yields
This stock pays an annual dividend of 0.82, which amounts to a dividend yield of 4.27%.
| Dividend Per Share | 0.82 |
| Dividend Yield | 4.27% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 72.61% |
| Buyback Yield | -0.49% |
| Shareholder Yield | 3.79% |
| Earnings Yield | 6.02% |
| FCF Yield | 11.27% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 19, 2022. It was a reverse split with a ratio of 0.8.
| Last Split Date | Jul 19, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.8 |
Scores
GSK plc has an Altman Z-Score of 1.83 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.83 |
| Piotroski F-Score | 6 |